Variable Success Rates of Haplo-Cord Transplants in High Risk Patients: A Minimum Serotherapy Exposure Is a Prerequisite for Sustainable Engrafting
Caroline A. Lindemans(University Medical Center Utrecht), Jaap Jan Boelens(Wilhelmina Children's Hospital), Jürgen Kuball(Utrecht University), A. M. J. Wensing(University Medical Center Utrecht), Rick Admiraal(NHS Blood and Transplant), Marc Bierings(University Medical Center Utrecht), C.M. Jol- van der Zijde(Leiden University Medical Center), Liane te Boome(University Medical Center Utrecht)
Cited by 1
Related Papers
Gut microbiome–derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease
|Nature Immunology|2016|727
Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis
|Blood|2016|554
Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually
|Bone Marrow Transplantation|2016|396